Concepedia

Hristo Metev

HM

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

2011

Affiliations

AstraZeneca (Sweden)(Current)

Angel Kanchev University of Ruse

Hristo Metev is an author at AstraZeneca (Sweden) specializing in pharmacy, pharmacotherapy, and clinical pharmacology.

Publications per year

2011–2020

6

Publications

6

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

, , +6

Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial

Paul M. O’Byrne, Hristo Metev, Margareta Puu et al. · The Lancet Respiratory Medicine · 2016 · 260 citations

, , +9

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Donald E. Low, Thomas M. File, Paul B. Eckburg et al. · Journal of Antimicrobial Chemotherapy · 2011 · 185 citations

, , +13

Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

Menno D. de Jong, Michael G. Ison, Arnold S. Monto et al. · Clinical Infectious Diseases · 2014 · 123 citations

, , +13

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)

Carlos M. Barrera, Analía Mykietiuk, Hristo Metev et al. · The Lancet Infectious Diseases · 2016 · 101 citations

, , +16

1–5 of 6